1. Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020

   • Kelly Virecoulon Giudici

   Conference Report Open access 07 February 2021 Pages: 118 - 122

2. Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline

   • J. R. Bock
   • Junko Hara
   • The Alzheimer’s Disease Neuroimaging Initiative

   Original Research Open access 11 November 2020 Pages: 123 - 126

   

3. Digital Screening for Cognitive Impairment — A Proof of Concept Study

   • Victor Bloniecki
   • G. Hagman
   • M. Kivipelto

   Original Research Open access 07 February 2021 Pages: 127 - 134

   

4. A Novel Computerized Cognitive Stress Test to Detect Mild Cognitive Impairment

   • Rosie E. Curiel Cid
   • E. A. Crocco
   • D. A. Loewenstein

   Original Research 07 February 2021 Pages: 135 - 141

5. A Web-Based Multidomain Lifestyle Intervention for Older Adults: The eMIND Randomized Controlled Trial

   • Philipe de Souto Barreto
   • K. Pothier
   • B. Vellas

   Original Research 04 December 2020 Pages: 142 - 150

   

6. Psychometric Properties of the Clinical Dementia Rating — Sum of Boxes and other Cognitive and Functional Outcomes in a Prodromal Alzheimer’s Disease Population

   • Fiona McDougall
   • C. Edgar
   • R. Doody

   Original Research Open access 21 December 2020 Pages: 151 - 160

   

7. Executive Function Predicts the Validity of Subjective Memory Complaints in Older Adults beyond Demographic, Emotional, and Clinical Factors

   • R.-Y. Chao
   • T.-F. Chen
   • Yu-Ling Chang

   Original Research 28 October 2020 Pages: 161 - 168

   

8. Mental Component Score (MCS) from Health-Related Quality of Life Predicts Incidence of Dementia in U.S. Males

   • Xiuhua Ding
   • E. L. Abner
   • R. J. Kryscio

   Original Research 18 September 2020 Pages: 169 - 174

   

9. Chinese Version of the Baylor Profound Mental Status Examination: A Brief Staging Measure for Patients with Severe Alzheimer’s Disease

   • X. Fu
   • W. Yu
   • Yang Lü

   Original Research 21 December 2020 Pages: 175 - 180

10. Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials

    • David A. Loewenstein
    • R. E. Curiel Cid
    • K. L. Gorman

    Original Research 07 February 2021 Pages: 181 - 187

11. Sugar in Beverage and the Risk of Incident Dementia, Alzheimer’s disease and Stroke: A Prospective Cohort Study

    • Hongyun Miao
    • Ken Chen
    • Fei Chen

    Original Research 09 November 2020 Pages: 188 - 193

    

12. Does Tea Drinking Promote Health of Older Adults: Evidence from the China Health and Nutrition Survey

    • J. Wang
    • Q. Wei
    • Xin Wan

    Original Research 28 November 2020 Pages: 194 - 198

13. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer’s Disease in a Cohort study: Methods, Baseline and Longitudinal Results of the A3C Study

    • Adelaide De Mauleon
    • J. Delrieu
    • J. P. Salles

    Original Research Open access 26 November 2020 Pages: 199 - 209

    

14. Cost-Effectiveness of Dementia Prevention Interventions

    • Ian McRae
    • L. Zheng
    • K. J. Anstey

    Original Research 15 December 2020 Pages: 210 - 217

15. Amyloid and APOE Status of Screened Subjects in the Elenbecestat MissionAD Phase 3 Program

    • Claire Roberts
    • J. Kaplow
    • M. Kanekiyo

    Original Research Open access 07 February 2021 Pages: 218 - 223

    

16. Molecular Subtyping of Mild Cognitive Impairment based on Genetic Polymorphism and Gene Expression

    • H.-T. Li
    • S.-X. Yuan
    • For the Alzheimer’s Disease Neuroimaging Initiative

    Original Research 23 November 2020 Pages: 224 - 233

    

17. Overtreating Alzheimer’s Disease

    • M. Canevelli
    • N. Vanacore
    • Matteo Cesari

    Reviews 31 December 2020 Pages: 234 - 236